‘On the Record’: Combating Cystic Fibrosis

‘On the Record’: Combating Cystic Fibrosis

A diagnosis led to a father going on a mission to fight cystic fibrosis. WPBF 25 goes “On the Record” with several South Florida organizations about their fight against the disease.

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis - Life Sciences British Columbia

In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and superior in reducing sweat chloride compared to TRIKAFTA Approximately 3,800 people in Canada are now eligible for ALYFTREK, with up to 60 people potentially eligible for a medicine that treats the underlying cause of their disease for the first time TORONTO, ON – Vertex Pharmaceuticals announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanza…